{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T06:37:04Z","timestamp":1698129424210},"reference-count":34,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"unspecified","delay-in-days":8470,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[1986,5]]},"abstract":"<jats:title>Synopsis<\/jats:title><jats:p>The effects on serum electrolytes of carbamazepine, an acute and prophylactic treatment for manic-depressive illness, were assessed in subjects with primary affective disorder. Carbamazepine caused statistically significant, but clinically insubstantial, reductions in serum sodium and calcium, but not in the other electrolytes measured. Decreases in serum sodium and calcium were not related to carbamazepine dose, blood levels, or the degree of clinical improvement. The theoretical implications of these findings are discussed.<\/jats:p>","DOI":"10.1017\/s0033291700009144","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T14:46:06Z","timestamp":1247150766000},"page":"331-335","source":"Crossref","is-referenced-by-count":11,"title":["Effects of carbamazepine on serum electrolytes in affectively ill patients"],"prefix":"10.1017","volume":"16","author":[{"given":"Russell T.","family":"Joffe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Uhde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"S0033291700009144_ref001","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6069.1134"},{"key":"S0033291700009144_ref011","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6053.83-a"},{"key":"S0033291700009144_ref029","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6063.754"},{"key":"S0033291700009144_ref013","first-page":"77","article-title":"Carbamazepine and bone mineral metabolism","volume":"69","author":"Hoikka","year":"1984","journal-title":"Acta Neurologica Scandinavica"},{"key":"S0033291700009144_ref033","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198304000-00009"},{"key":"S0033291700009144_ref008","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-5-952"},{"key":"S0033291700009144_ref023","first-page":"220","volume-title":"Advances in Epileptology, 1977: Psychology, Pharmacotherapy and New Diagnostic Approaches","author":"Porter","year":"1978"},{"key":"S0033291700009144_ref010","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6086.558"},{"key":"S0033291700009144_ref003","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1963.01720150090010"},{"key":"S0033291700009144_ref006","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1971.tb04380.x"},{"key":"S0033291700009144_ref027","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6090.804"},{"key":"S0033291700009144_ref009","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197612030-00003"},{"key":"S0033291700009144_ref024","first-page":"10","article-title":"Carbamazepine in bipolar illness","volume":"21","author":"Post","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"key":"S0033291700009144_ref028","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1978.03630260085022"},{"key":"S0033291700009144_ref031","first-page":"A62","article-title":"Calcium metabolism in epileptic patients treated with carbamazepine","volume":"35","author":"Tjellesen","year":"1983","journal-title":"Calcium Tissue International"},{"key":"S0033291700009144_ref026","doi-asserted-by":"publisher","DOI":"10.1016\/0221-8747(82)90038-8"},{"key":"S0033291700009144_ref012","first-page":"A46","article-title":"Carbamazepine and bone mineral metabolism","volume":"35","author":"Hoikka","year":"1983","journal-title":"Calcified Tissue International"},{"key":"S0033291700009144_ref030","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6125.1445"},{"key":"S0033291700009144_ref018","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1976.tb06747.x"},{"key":"S0033291700009144_ref007","first-page":"374","article-title":"Carbamazepine in the treatment of tabetic lightening pain","volume":"26","author":"Ekbom","year":"1972","journal-title":"Archives of General Psychiatry"},{"key":"S0033291700009144_ref004","first-page":"340","volume-title":"Neurobiology of Mood Disorders","author":"Carman","year":"1984"},{"key":"S0033291700009144_ref021","first-page":"282","article-title":"Biochemical evidence for osteomalacia with carbamazepine theraphy","volume":"72","author":"O'Hare","year":"1980","journal-title":"Acta Neurologica Scandinavica"},{"key":"S0033291700009144_ref025","first-page":"777","volume-title":"Neurobiology of Mood Disorders","author":"Post","year":"1984"},{"key":"S0033291700009144_ref005","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.111.481.1133"},{"key":"S0033291700009144_ref017","first-page":"289","article-title":"The antidiuretic action of carbamazepine in man","volume":"47","author":"Meinders","year":"1974","journal-title":"Clinical Science and Molecular Medicine"},{"key":"S0033291700009144_ref020","first-page":"A58","article-title":"Bone histomorphometry, vitamin D metabolites and calcium-phosphate metabolism in anticonvulsant treatment with carbamazepine","volume":"35","author":"Nielsen","year":"1983","journal-title":"Calcified Tissue International"},{"key":"S0033291700009144_ref032","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1983.tb04854.x"},{"key":"S0033291700009144_ref014","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700015142"},{"key":"S0033291700009144_ref019","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700047413"},{"key":"S0033291700009144_ref002","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(82)90458-1"},{"key":"S0033291700009144_ref015","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-38-3-356"},{"key":"S0033291700009144_ref022","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.41.8.713"},{"key":"S0033291700009144_ref016","first-page":"347","article-title":"Levels of serum enzymes, calcium and inorganic phosphorus in epileptic patients treated with antiepileptic drugs","volume":"36","author":"Kondo","year":"1982","journal-title":"Folia Psychiatrica et Neurologica Japonica"},{"key":"S0033291700009144_ref034","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(75)90361-X"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291700009144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:10:13Z","timestamp":1558505413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291700009144\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1986,5]]}},"alternative-id":["S0033291700009144"],"URL":"https:\/\/doi.org\/10.1017\/s0033291700009144","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,5]]}}}